If smoking, oils or capsules aren't your favourite way to consume cannabis, there's now another legal way to do so.
Grasshopper Retail Inc.and Zaga's Hemp Shop Prince George are officially selling edibles as of Jan.2 - although the products were made legal in October. Items can include chocolates, gummies, tea, mints, distillate pens and cartridges currently.
The Government of Canada officially announced proposed rules back in December, 2019.
One of the most significant restrictions is a ban on adding alcohol to cannabis food and beverage products. There is also a ban on the addition of nicotine, caffeine, sweeteners, sugars and colours to cannabis extracts. In addition, no cannabis products can have elements that would associate it with alcohol or alcohol brands.
Both food and beverage products are limited to 10 mg of THC per container, the psychoactive component of cannabis. Concentrated THC products have a maximum package size of 7.5 grams and inhaled cannabis extracts are limited to a package size of 90 ml.
Like cannabis flowers, there are also strict rules on labelling and packaging. Additional cannabis products must be sold in plain, child-resistant packaging with labels that are not appealing to children.
"The demand has been huge. The citizens of Prince George have been waiting for a long time for legalization 2.0," says a Grosshopper Inc. representative.
Stores can carry flavours including sativa raspberry gummies, 60 per cent dark chocolate cocoa, sea salt caramel milk chocolate, spearmint chillers, bakerstreet and peppermint milk chocolate, soft-baked chocolate cookies as well as teas (each store will vary in the product.)
The edibles mostly come 10 mg/package. For example, if there are five gummies in a package, one gummy would be roughly two milligrams.
You can find Grasshopper Retail Inc. in downtown Prince George at 421 George St. while you can find Zaga's Hemp Shop at Redwood Square, 1543 Victoria St.
- With files from Albert Van Santvoort, Business in Vancouver
This sector is so young .... but growing globally.... look at this.
European savers will soon be offered their first opportunity to invest in an exchange traded fund focused on the fast-growing legal marijuana industry. Canadian fund group Purpose Investments plans to launch the Medical Cannabis and Wellness ETF from January 13, which will be Europe’s first such product. The fund will be listed in Germany and made available to investors in the UK, Italy and Ireland.
Aphria Inc (NYSE:APHA) – Equities research analysts at Jefferies Financial Group issued their Q3 2020 earnings estimates for Aphria in a research report issued to clients and investors on Tuesday, December 31st. Jefferies Financial Group analyst O. Bennett expects that the company will earn ($0.01) per share for the quarter. Jefferies Financial Group has a “Buy” rating and a $8.30 price objective on the stock. Jefferies Financial Group also issued estimates for Aphria’s Q4 2020 earnings at $0.05 EPS and FY2022 earnings at $0.31 EPS.
APHA has been the topic of a number of other research reports. Pi Financial set a $9.00 target price on Aphria and gave the company a “buy” rating in a research report on Tuesday, October 15th. CIBC reaffirmed a “sell” rating and set a $6.50 price target on shares of Aphria in a research report on Wednesday, October 16th. ValuEngine cut shares of Aphria from a “buy” rating to a “hold” rating in a research note on Thursday, December 5th. Zacks Investment Research upgraded shares of Aphria from a “hold” rating to a “buy” rating and set a $6.25 price objective on the stock in a report on Monday, December 16th. Finally, Cantor Fitzgerald began coverage on shares of Aphria in a research report on Tuesday, November 5th. They issued an “overweight” rating and a $10.40 price objective on the stock. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the stock. Aphria has a consensus rating of “Buy” and an average price target of $12.03.
NYSE:APHA opened at $4.96 on Friday. The company has a market cap of $1.26 billion, a PE ratio of -45.09 and a beta of 2.78. Aphria has a 52-week low of $3.76 and a 52-week high of $10.95. The stock has a 50-day simple moving average of $4.83 and a 200 day simple moving average of $5.73.
Aphria (NYSE:APHA) last released its quarterly earnings results on Tuesday, October 15th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.10. The firm had revenue of $126.10 million during the quarter, compared to analyst estimates of $131.15 million. Aphria’s revenue for the quarter was up 848.1% on a year-over-year basis.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Synovus Financial Corp grew its stake in shares of Aphria by 56.9% in the second quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock valued at $39,000 after buying an additional 2,000 shares in the last quarter. Creative Planning lifted its stake in Aphria by 2.9% in the third quarter. Creative Planning now owns 74,332 shares of the company’s stock valued at $386,000 after acquiring an additional 2,073 shares during the last quarter. Virtu Financial LLC lifted its stake in Aphria by 14.9% in the third quarter. Virtu Financial LLC now owns 18,365 shares of the company’s stock valued at $95,000 after acquiring an additional 2,380 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Aphria by 76.0% in the second quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock valued at $44,000 after acquiring an additional 2,698 shares during the last quarter. Finally, Sfmg LLC grew its position in shares of Aphria by 15.0% in the 3rd quarter. Sfmg LLC now owns 28,607 shares of the company’s stock valued at $148,000 after acquiring an additional 3,737 shares during the period. Institutional investors own 9.60% of the company’s stock.
Aphria Company Profile
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.